Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 8:
CorMedix Inc. CRMD: This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 20.7% over the last 60 days.
CorMedix's shares gained 165.8% over the last three months compared with the S&P 500’s advanced of 12.2%. The company possesses a Momentum Score of A.
Flushing Financial Corporation FFIC: This bank holding company for Flushing Bank has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.6% over the last 60 days.
Flushing Financial Corporation's shares gained 36.6% over the last three months compared with the S&P 500’s advanced of 12.2%. The company possesses a Momentum Score of A.
Sappi Limited SPPJY: This wood fiber-based renewable resources company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 16.7% over the last 60 days.
Sappi Limited's shares gained 19.9% over the last three months compared with the S&P 500’s advanced of 12.1%. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Free: 5 Stocks to Buy As Infrastructure Spending Soars
Trillions of dollars in Federal funds have been earmarked to repair and upgrade America’s infrastructure. In addition to roads and bridges, this flood of cash will pour into AI data centers, renewable energy sources and more.
In, you’ll discover 5 surprising stocks positioned to profit the most from the spending spree that’s just getting started in this space.
Download How to Profit from the Trillion-Dollar Infrastructure Boom absolutely free today.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Flushing Financial Corporation (FFIC): Free Stock Analysis Report
Sappi Ltd. (SPPJY): Free Stock Analysis Report
CorMedix Inc (CRMD): Free Stock Analysis Report